ProKidney Corp.

Stock Chart, Company Information, and Scan Results

$2.69(as of Jul 30, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

ProKidney Corp. Company Information, Fundamentals, and Technical Indicators

Stock Price$2.69
Ticker SymbolPROK
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees204
CountyUSA
Market Cap$1,805.3M
EBIDTA-173.7M
10-Day Moving Average3.13
P/E Ratio-5.07
20-Day Moving Average3.08
Forward P/E Ratio0.00
50-Day Moving Average1.70
Earnings per Share-0.59
200-Day Moving Average1.49
Profit Margin-7,275.65%
RSI51.27
Shares Outstanding133.4M
ATR0.57
52-Week High5.95
Volume1,197,595
52-Week Low0.46
Most Recent Support Level2.80
Book Value370.0M
Most Recent Resistance Level3.50
P/B Ratio0.94
Upper Keltner4.36
P/S Ratio1,133.81
Lower Keltner1.80
Debt-to-Equity Ratio4.36
Next Earnings Date08/07/2025
Cash Surplus65.0M
Next Ex-Dividend DateUnknown

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

ProKidney Corp. In Our Stock Scanner

As of Jul 30, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.